by Jose Trasancos | Nov 17, 2024 | Abortion, News, Vaccines
The FDA announced approval of a new RSV mRNA vaccine on October 23, 2024. This vaccine was developed and tested in a collaborative effort between ModernaTX and Merck and is intended for administration to adults 60 years of age or older. The press release announcing...
by Jose Trasancos | Aug 28, 2024 | Abortion, Fetal & Vaccine Research, News
We recently published an update on seasonal influenza shots and very quickly received a number of questions about the use of mRNA technology in influenza shots. A brief mention was made in the update, but a little more detail will be useful in understanding the...
by Jose Trasancos | Sep 21, 2023 | Abortion, Fetal & Vaccine Research, Vaccines
Two RSV (Respiratory Syncytial Virus) vaccines have been approved in 2023 – Arexvy (GSK) and Abrysvo (Pfizer). Arexvy is recommended for adults over 60 years of age and Abrysvo has also been recommended for administration to expectant mothers between 32 and 36...
by Jose Trasancos | May 16, 2022 | Abortion, Fetal & Vaccine Research, News, Vaccines
Our Frequently Asked Questions page has been updated with information on a recently authorized monoclonal antibody, developed by Eli Lilly. Like so many others, this monoclonal antibody owes its existence to the continued exploitation of aborted children. What follows...
by Jose Trasancos | Mar 2, 2022 | Abortion, International, Legislative, News, Vaccines
These vaccine candidates have been in the news lately, and we’ve received a number of inquiries with respect to their ethics and potential availability. Let’s address these questions. Corbevax Corbevax made the news in late December of last year, following its...
Want information to be in English
Dear GOD! Have mercy on this. Makes me want to vomit.